Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

This study has been completed.

Study NCT00027703 Information provided by National Cancer Institute (NCI)

First Received: December 7, 2001 Last Updated: September 17, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)

Publications:

Kindler HL, Karrison T, Lu C, et al.: A multicenter, double-blind, placebo-controlled randomized phase II trial of gemcitabine/cisplatin (GC) plus bevacizumab (B) or placebo in patients (pts) with malignant mesothelioma (MM). [Abstract] J Clin Oncol 23 (Suppl 16): A-7019, 625s, 2005.